Monday, November 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

BMO Capital Analysts Remain Bullish on Bath Body Works Increase Price Target to 50

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
DrugRetailers Trading online
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 1, 2024, BMO Capital analyst Simeon Siegel reiterated an Outperform rating on Bath & Body Works (NYSE: BBWI) and increased the price target to $50. This adjustment reflects a bullish view on the company’s potential for growth.

The firm’s analysts are optimistic about Bath & Body Works’ performance, citing significant margin improvements as a key factor in their confidence in the stock. This positive outlook is supported by a consensus among analysts surveyed by Capital IQ, who have given the company an average Outperform rating with price targets ranging up to $40.

Despite a recent dip in stock performance due to disappointing guidance, BMO Capital Markets remains bullish on Bath & Body Works. Following a strong Q4 report and what they believe to be a conservative forecast from the company, analysts have reiterated their positive outlook on its future prospects.

BBWI Stock Price Drops 5.36% in March 2024: Should Investors Be Concerned?

On March 1, 2024, BBWI stock experienced a significant drop in its price performance. The stock closed at $45.70, which was already near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum. However, the stock saw a decrease of $2.59, or a 5.36% drop, since the market last closed.

In pre-market trading, BBWI stock continued to decline, dropping an additional $0.20. This downward trend in the stock’s price performance may be concerning for investors who were previously optimistic about the stock’s potential.

BBWI Stock Performance Analysis: Revenue Growth and EPS Increase, Net Income Holds Flat

On March 1, 2024, BBWI stock showed mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $7.43 billion for the past year, which remained flat compared to the previous year. However, there was a significant increase of 86.43% in total revenue since the last quarter, reaching $2.91 billion.

The net income for BBWI was $878.00 million for the past year, showing a 9.75% increase compared to the previous year. On the other hand, the net income held flat at $579.00 million since the last quarter. Earnings per share (EPS) for the company were reported at $3.83 for the past year, reflecting an 11.67% increase compared to the previous year. The EPS also saw a substantial increase of 388.73% since the last quarter, reaching $2.55.

Overall, BBWI stock showed a strong performance in terms of revenue growth, particularly in the last quarter. The increase in total revenue and EPS indicate positive momentum for the company. However, the flat net income since the last quarter may raise some concerns among investors. It will be interesting to see how BBWI stock performs in the coming months and whether the company can sustain its growth trajectory. Investors should keep a close eye on the financial indicators and market trends to make informed decisions regarding BBWI stock.

Tags: BBWI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Sleep

Analyzing Short Interest in Iovance Biotherapeutics NYSEIOVA

Neurotechnology

Analyst Reaffirms Positive Outlook on DoubleVerify Holdings with Lower Price Target

Financing and finances

Goldman Sachs Analyst Reiterates Sell Rating on Autodesk

Recommended

Renewable energy

Barclays Analyst Upgrades Icons Price Target Remains Positive

2 years ago
Clear Channel Outdoor Stock

Clear Channel Outdoor: A Contradictory Path to Recovery

2 months ago
Entertainment Markets and money (1)

IMAXs Dune Part 2 Shatters Box Office Records and Sets Stage for Global Expansion

2 years ago
GoPro Stock

GoPro’s Three-Pronged Product Launch Aims to Reignite Growth

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Circle Shares Face Pressure Ahead of Earnings Report

MercadoLibre’s Growth Strategy Tests Investor Patience

Defense Giant Raytheon Capitalizes on Global Security Demands

Exxon Mobil’s Major LNG Venture Nears Critical Development Phase

CoreWeave Shares Face Critical Earnings Test

Riot Blockchain Faces Critical Juncture Amid Diverging Business Lines

Trending

Arrowhead Stock
Analysis

Arrowhead Pharmaceuticals Faces Pivotal Regulatory Week

by Felix Baarz
November 10, 2025
0

Investors in Arrowhead Pharmaceuticals are bracing for significant volatility as the biotechnology firm approaches two major regulatory...

Fluence Energy Stock

Fluence Energy Shares Surge on Major German Energy Storage Contract

November 10, 2025
Ares Capital Stock

Ares Capital: CEO Confidence Clashes with Analyst Caution

November 10, 2025
Circle Stock

Circle Shares Face Pressure Ahead of Earnings Report

November 10, 2025
MercadoLibre Stock

MercadoLibre’s Growth Strategy Tests Investor Patience

November 10, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Arrowhead Pharmaceuticals Faces Pivotal Regulatory Week
  • Fluence Energy Shares Surge on Major German Energy Storage Contract
  • Ares Capital: CEO Confidence Clashes with Analyst Caution

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com